Wellington Management Group
ALDR

Wellington Management Group’s Alder Biopharmaceuticals ALDR Stock Holding History

Wellington Management Group’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,272,054
Closed -$121M – 2177
2019
Q2 		$121M Buy
10,272,054
+112,972
+1% +$1.37M 0.03% 510
2019
Q1 		$139M Buy
10,159,082
+5,393,959
+113% +$69.9M 0.03% 464
2018
Q4 		$48.8M Buy
4,765,123
+624,954
+15% +$8M 0.01% 714
2018
Q3 		$68.9M Sell
4,140,169
-759,786
-16% -$13.7M 0.01% 696
2018
Q2 		$77.4M Sell
4,899,955
-88,523
-2% -$1.35M 0.02% 661
2018
Q1 		$63.4M Buy
4,988,478
+473,385
+10% +$6.85M 0.01% 710
2017
Q4 		$51.7M Sell
4,515,093
-397,777
-8% -$4.44M 0.01% 762
2017
Q3 		$60.2M Buy
4,912,870
+1,315,639
+37% +$13.7M 0.01% 694
2017
Q2 		$41.2M Sell
3,597,231
-43,557
-1% -$805K 0.01% 792
2017
Q1 		$75.7M Buy
3,640,788
+26,791
+0.7% +$593K 0.02% 593
2016
Q4 		$75.2M Sell
3,613,997
-222,275
-6% -$5.78M 0.02% 594
2016
Q3 		$126M Sell
3,836,272
-543,691
-12% -$16.6M 0.03% 418
2016
Q2 		$109M Buy
4,379,963
+1,223,098
+39% +$33.1M 0.03% 453
2016
Q1 		$77.3M Buy
3,156,865
+1,803,110
+133% +$41.7M 0.02% 544
2015
Q4 		$44.7M Buy
1,353,755
+1,314,206
+3,323% +$44.4M 0.01% 705
2015
Q3 		$1.3M Sell
39,549
-5,620
-12% -$239K ﹤0.01% 1770
2015
Q2 		$2.39M Sell
45,169
-183,000
-80% -$6.66M ﹤0.01% 1621
2015
Q1 		$6.58M Sell
228,169
-80,020
-26% -$2.2M ﹤0.01% 1366
2014
Q4 		$8.96M Buy
308,189
+65,770
+27% +$1.18M ﹤0.01% 1279
2014
Q3 		$3.07M Buy
242,419
+87,500
+56% +$1.32M ﹤0.01% 1575
2014
Q2 		$3.11M Buy
+154,919
New +$2.18M ﹤0.01% 1576

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group's ALDR Position: Q3 2019 in Review

Wellington Management Group sold out of Alder Biopharmaceuticals (ALDR) in Q3 2019, closing a stake of 10,272,054 shares — an estimated $121M sold.

Wellington Management Group first reported a position in ALDR in Q2 2014 and held it in 21 quarters. The position peaked at $139M in Q1 2019. 143 funds tracked by Wall St. Rank hold ALDR as of Q3 2019.

  • Wellington Management Group reported no remaining Alder Biopharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Wellington Management Group sold 10,272,054 Alder Biopharmaceuticals shares in Q3 2019, an estimated $121M.
  • Wellington Management Group first reported a position in Alder Biopharmaceuticals in Q2 2014 and held it in 21 quarters.
  • Wellington Management Group's Alder Biopharmaceuticals position peaked at $139M in Q1 2019.
  • 143 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2019.

Based on Wellington Management Group's 13F filing for Q3 2019, filed 13 Nov 2019.